ProQR Therapeutics is a NASDAQ-listed biotechnology company headquartered in Leiden, the Netherlands, with an office in Cambridge, Massachusetts, USA, developing innovative RNA-editing medicines through its proprietary Axiomer platform. Our mission is to edit RNA, treat disease
Radboud University Medical Center UI Institute seeks a PhD researcher to develop AI-driven protein engineering approaches for targeting retinal diseases. Solliciteer nu, lees de vacaturedetails door naar beneden te scrollen. Controleer of u over de nodige
Job description Heeft u wat nodig is om te slagen? De volgende informatie dient door alle kandidaten zorgvuldig gelezen te worden. Inherited retinal diseases are an important causes of blindness. Currently, various types of genetic therapy
Grünenthal Group in the Netherlands is seeking a senior researcher to lead the design and computational optimisation of RNA therapeutics, including siRNA, blending RNA biology with oligonucleotide chemistry to drive gene knockdown and regulatory strategies. xgiwjmb De